Prenatal and molecular diagnosis of hemophilia B

American Journal of Hematology

Volumn 52, Issue 4, 1996, Pages 243-247

  Young, Ji Hsiung ^a   Wang, Jyh Chwan ^a   Gau, Jyh Pyng ^a   Hu, Han Tien ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

factor IX; hemophilia B; mutation; prenatal diagnosis

Indexed keywords

BLOOD CLOTTING FACTOR 9;

AMINO ACID SUBSTITUTION; ARTICLE; DIAGNOSTIC VALUE; FETUS; GENE MUTATION; HEMOPHILIA B; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

BASE SEQUENCE; CHORIONIC VILLI SAMPLING; DNA; DNA PRIMERS; FACTOR IX; FEMALE; HEMOPHILIA B; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; SEQUENCE ANALYSIS, DNA;

EID: 0029781043     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199608)52:4<243::AID-AJH1>3.0.CO;2-S     Document Type: Article

References (26)

1. Camerino G, Grzeschik KH, Jaye M, De La Salle H, Tolstoshev P, Lecocq JP, Heiling R, Mandel JL: Regional localization on the human X-chromosome and polymorphism of the coagulation factor IX gene (hemophilia-B locus). Proc Natl Acad Sci USA 81:498-502, 1984.
2. Chance PF, Dyer KA, Kurachi K, Yoshitake S, Ropers HH, Wieacker P, Gartler SM: Regional localization of the human factor IX gene by molecular hybridization. Hum Genet 65:207-208, 1983.
3. Schwartz C, Fitch N, Phelan MC, Richer CK, Stevenson R: Two sisters with a distal deletion at the Xq28/Xq27 interface: DNA studies indicate that the gene locus for factor IX is present. Hum Genet 76:54-57, 1987.
4. Anson DS, Choo KH, Rees DJG, Giannelli F, Gould K, Huddleston JA, Brownlee GG: The gene structure of human anti-haemophilic factor IX. EMBO J 3:1053-1060, 1984.
5. Choo KH, Gould KG, Rees DJG, Brownlee GG: Molecular cloning of the gene for human anti-hemophilic factor IX. Nature 299:178-180, 1982.
6. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K: Nucleotide sequence of the gene for human factor IX (anti-hemophilic factor B). Biochemistry 24:3736-3750, 1985.
7. Giannelli F, Green PM, Sommer SS, Lillicrap DP, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG: Haemophilia B: Database of point mutations and short additions and deletions, fourth edition, 1994. Nucleic Acids Res 22:3534-3546, 1994.
8. Thompson AR: Molecular biology of the hemophilas. Prog Hematol 10:195-214, 1991.
9. Chang JG, Chen PH, Chiou SS, Lee LS, Perng LI, Liu TC: Rapid diagnosis of beta-thalassemia mutation in Chinese by naturally and amplified created restriction sites. Blood 80:2092-2096, 1992.
10. Eiken H, Odland E, Boman H, Skjelkvale L, Engebretsen L, Apold J: Application of natural and amplification created restriction sites for the diagnosis of PKU maturation. Nucleic Acids Res 19:1427-1430, 1991.
11. Chang JG, Chiou SS, Perng LI, Chen TC, Liu TC, Lee LS, Chen PH, Tang TK: Molecular characterization of glucose-6-phosphatase dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: Five mutations account for most G6PD deficiency case in Taiwan. Blood 80:1079-1082, 1992.
12. Bertina RM, van der Linden: Detection and classification in molecular variants of factor IX. In Bloom AL (ed); "The Hemophilias, Methods in Hematology," Vol. 5. Churchill Livingstone, 1982, pp. 137-155.
13. Maniatis T, Fritsch EF, Sambrook J: "Molecular Cloning." New York: Cold Spring Harbor Laboratory Press, 1982, pp 458-459.
14. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467, 1977.
15. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225-235, 1992.
16. Olerup O, Aldener A, Fogdell A: HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41:119-134, 1993.
17. Giannelli F, Choo KH, Winship PR, Rizza OR, Anson DS, Rees DJG, Ferrari N, Brownlee GG: Characterization and use of an intragenic polymorphic marker for detection of carriers of hemophilia B (factor IX deficiency). Lancet 1:239-241, 1984.
18. Lillicrap DP, White BN, Holden JJ, Giles AR: Carrier detection in the hemophilias. Am J Hematol 26:285-296, 1987.
19. Tagliavacca L, Sacchi E, Mannucci PM: Carrier detection and feasibility of prenatal diagnosis of hemophilia B by multiplex polymerase chain reaction. Int J Clin Lab Res 23:169-171, 1993.
20. Tanimoto M: Extragenic factor IX gene RFLP is useful for detecting carriers of Japanese hemophilia-B. Nippon Ketsueki Gakkai Zasshi 52:774-777, 1989.
21. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA: Analysis of enzymatically amplified beta-globulin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324:163-166, 1986.
22. Wu DY, Ugozzoli L, Pal BK, Wallace RB: Allele-specific enzymatical amplification of beta-globulin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci USA 86:2757-2760, 1989.
23. Lin SW, Shen MC: Genetic basis and carrier detection of hemophilia B of Chinese origin. Thromb Haemost 69:247-252, 1993.
24. Reiss J, Neufeldt U, Wieland K, Zoll B: Diagnosis of haemophilia B using the polymerase chain reaction. Blut 60:31-36, 1990.
25. Rees DJG, Rizza CR, Brownlee GG: Haemophilia B caused by a point mutation in a donor splice junction of the human factor IX gene. Nature 316:643-645, 1985.
26. Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A: Modification of enzymatically amplified DNA for the detection of point mutation. Nucleic Acids Res 17:3606, 1989.